Hair loss is such a common experience that many people go through, but it can seem like it hits us out of nowhere. There are ...
Dr Myro Figura, an anesthesiologist from Los Angeles, has shared a video on Instagram explaining why you might want to avoid ...
It’s time that insurance recognizes wigs as necessary medical expenses for those suffering from conditions like alopecia, ...
42.4% of adolescents with severe alopecia areata who received baricitinib had 80% or more scalp hair coverage after 36 ... and 6% to 9% were Black or African American. All the participants ...
Eli Lilly’s Olumiant is facing tough competition in its approved rheumatoid arthritis indication, but could take the lead in alopecia areata (AA), a common cause of hair loss. The FDA has ...
If you have alopecia areata, it’s very important to keep tabs on your emotions, and, if necessary, get help. It’s very normal to have these feelings. Your hair is often linked to your personal ...
Crystal Aguh, MD, FAAD, Johns Hopkins School of Medicine faculty, highlights the critical need for comprehensive education on hair loss across diverse hair types, stressing the importance of ...
Alopecia areata incidence was highest in patients in North America, Southeast Asia, and Australia, as well as in women and those aged 30 to 34 years.
Patients with severe to very severe alopecia areata saw hair regrowth with bempikibart treatment within 24 weeks. Hair regrowth seemed to persist after treatment cessation to week 36. ORLANDO ...
At week 36, 42.4 and 27.4% of patients receiving baricitinib 4mg and baricitinib 2mg, respectively, achieved a SALT score of less than or equal to 20 compared with 4.5% of patients receiving placebo.
Researchers conducted a retrospective review of 241 patients (82.6% women; mean age, 58.4 years; 49.8% White; 14.1% Black) diagnosed with lymphocytic scarring alopecia between 2009 and 2023 to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results